Helping choose the right antibiotic for sepsis
Part of Infections clinical trials.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and admitted to the hospital.
- You started one of these IV antibiotics within the last day: Vancomycin, Linezolid, Daptomycin, Clindamycin, Cefazolin, Cloxacillin, Ceftriaxone, Ceftazidime, Piperacillin-Tazobactam, Meropenem, Imipenem, Ertapenem, or Ciprofloxacin.
- Blood cultures were taken within 12 hours before or after starting the antibiotic.
- You are not pregnant or breastfeeding.
- You are not being treated for cystic fibrosis or only receiving antibiotics before or after surgery.
- You are not already in another antibiotic trial and you are not receiving end-of-life care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
This trial is testing a new tool that uses artificial intelligence and biomarkers (substances in your blood) to help doctors recognize sepsis earlier. If you have been diagnosed with sepsis or are suspected of having it, this study may help improve how quickly and accurately it's detected.
This study looks at past patient records to build a tool that can predict whether sepsis infections are resistant to multiple antibiotics. If you had sepsis in the emergency department, your data may help improve treatment decisions for future patients.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.